Başkent Üniversitesi Yayınları

Permanent URI for this communityhttps://hdl.handle.net/11727/13092

Browse

Filters

2011 - 20122

Settings

Author: search.filters.author.Dayangac, MuratSubject: search.filters.subject.Liver transplant

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Living-donor Liver Transplant in 3 Patients With Budd-Chiari Syndrome: Case Report
    (Başkent Üniversitesi, 2012-04) Bas, Koray; Tokat, Yaman; Yuzer, Yildiray; Dogusoy, Gulen Bulbul; Ulusoy, Onur Levent; Dayangac, Murat; Yaprak, Onur
    Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on the underlying cause, the location, and extent of the obstruction, and the functional capacity of the liver. A stepwise therapeutic approach is commonly accepted. When all other therapy options are unsuccessful, or in case of end-stage liver disease, transplant should be considered. We present case reports of 3 patients with Budd-Chiari syndrome who underwent living-donor liver transplant. Characteristic features of Budd-Chiari syndrome, diagnostic and therapeutic interventions, complications, and overall outcomes are discussed. We believe that when a deceased donor graft is unavailable, a living-donor liver transplant can be a safe option for patients with end-stage liver disease associated with Budd-Chiari syndrome.
  • No Thumbnail Available
    Item
    Analysis of Right Lobe Living-Liver Donor Complications: A Single Center Experience
    (Başkent Üniversitesi, 2011-02) Yaprak, Onur; Tokat, Yaman; Yuzer, Yildiray; Tabendeh, Babek; Demirbas, B. Tolga; Dayangac, Murat
    Objectives: Living-donor liver transplant provides an alternative source of organ to patients with end-stage liver disease. This study sought to determine and classify the donor morbidities after right lobe donor hepatectomy in a single center. Materials and Methods: One-hundred eighty-one right lobe living-donor hepatectomy were performed in our center between January 2004 and December 2009. Of the 181 donors, 104 donors were men and 77 donors were women. Mean age of the donors was 38 years (range, 18-63 years). The mean follow-up was 33.3 months (range, 3-66 months). Complications after the operation were stratified according to the Clavien classification. Results: Eighty-one complications occurred in 73 of the 181 donors (40.3%). The most common complication was wound infection, which was seen in 14 of 181 donors (7.7%). Biliary complications were seen in 4.4% of donors. There was no postoperative mortality. Also, grade 4 complications, which are life-threatening, did not occur. Blood transfusion were not required during the operation. The incidence of reoperation was 1.6% in all donors. Conclusions: Living-donor liver transplant ensures a new graft to patients with end-stage liver disease. Donor morbidity is one of the realities of the donor hepatectomy procedure. Because the donors are healthy individuals, the aim of the process must be to eliminate the donor mortality while decreasing the complication rates.